MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 05-30-2026
Surmodics Total Current Liabilities 2011-2026 | SRDX
Annual Total Current Liabilities Surmodics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20.5 M | 24 M | 32.1 M | 29.8 M | 18.9 M | 20.2 M | 35.1 M | 9.8 M | 10.1 M | 4.7 M | 4.07 M | 5.98 M | 6.9 M | 11 M | 7.65 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 35.1 M | 4.07 M | 16.1 M |
Total Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K |  USA |
 |
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | USA |
 |
Celcuity
CELC
|
44.2 M | $ 88.57 | -4.22 % | $ 4.14 B | USA |
 |
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
3.54 M | $ 5.32 | -7.68 % | $ 7.08 M | USA |
 |
Castle Biosciences
CSTL
|
68.7 M | $ 21.2 | -1.85 % | $ 615 M | USA |
 |
Fulgent Genetics
FLGT
|
85 M | $ 19.02 | -2.46 % | $ 585 M | USA |
 |
Aspira Women's Health
AWH
|
3.46 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
31.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Guardant Health
GH
|
303 M | $ 126.28 | -5.1 % | $ 15.8 B | USA |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
Interpace Biosciences
IDXG
|
5.1 M | $ 1.65 | -7.82 % | $ 7.3 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
89.8 M | $ 22.06 | -4.58 % | $ 1.18 B | USA |
 |
Illumina
ILMN
|
1.58 B | $ 161.86 | -3.69 % | $ 25.1 B | USA |
 |
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
4.05 M | - | - | $ 9.42 M |  Israel |
 |
ICON Public Limited Company
ICLR
|
3.2 B | $ 148.91 | -2.55 % | $ 11.7 B |  Irlanda |
 |
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
333 M | $ 101.99 | -0.81 % | $ 6.88 B | USA |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | USA |
 |
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
NeoGenomics
NEO
|
88.3 M | $ 10.82 | -4.33 % | $ 1.39 B | USA |
 |
Natera
NTRA
|
441 M | $ 215.8 | -2.84 % | $ 29.5 B | USA |
 |
Charles River Laboratories International
CRL
|
1.12 B | $ 182.78 | -1.63 % | $ 9.06 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | USA |
 |
Pacific Biosciences of California
PACB
|
72.8 M | $ 1.4 | -13.85 % | $ 420 M | USA |
 |
Medpace Holdings
MEDP
|
1.34 B | $ 455.2 | -0.76 % | $ 13.1 B | USA |
 |
Mettler-Toledo International
MTD
|
1.2 B | $ 1 154.6 | -2.19 % | $ 23.8 B |  Schweiz |
 |
Exact Sciences Corporation
EXAS
|
641 M | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
134 M | $ 4.63 | -1.39 % | $ 429 M | USA |
 |
National Research Corporation
NRC
|
36.6 M | $ 19.56 | -0.96 % | $ 438 M | USA |
 |
Personalis
PSNL
|
39.6 M | $ 10.54 | -12.93 % | $ 941 M | USA |
 |
Senseonics Holdings
SENS
|
24.3 M | $ 6.63 | -5.49 % | $ 277 M | USA |
 |
QIAGEN N.V.
QGEN
|
512 M | - | - | $ 10.6 B |  Niderland |
 |
Soleno Therapeutics
SLNO
|
61.4 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
1.74 M | $ 2.15 | 0.23 % | $ 4.94 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
2.82 B | $ 266.2 | 1.95 % | $ 22.1 B | USA |
 |
Twist Bioscience Corporation
TWST
|
91.4 M | $ 68.92 | -6.78 % | $ 4.12 B | USA |
 |
Thermo Fisher Scientific
TMO
|
15.2 B | $ 474.12 | -1.65 % | $ 179 B | USA |
 |
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | Israel |
 |
Waters Corporation
WAT
|
1.24 B | $ 367.04 | -2.49 % | $ 21.9 B | USA |
 |
Neogen Corporation
NEOG
|
174 M | $ 8.99 | -1.48 % | $ 1.95 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.28 B | $ 201.12 | 2.53 % | $ 22.3 B | USA |